Anti-Mouse CD40 Ligand/TNFSF5 Affinity Purified Polyclonal Ab

データシート

• 商品コード：AF1163-SP
• メーカー：RSD
• 包装：25μg
• 価格： ¥30,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  de Silva S et al. CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity. Cancer Immunol Res 2020 02;8(2):230-245
  de Silva S et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: Western Blot
• 参照：
  

• No.： 2
• 文献情報：
  Liu J et al. CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individua
  Liu J et al
  2008/01/01
  
• 備考：
  Species: Mouse, Applications: Western Blot
• 参照：
  

• No.： 3
• 文献情報：
  Gupta S et al. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. J. Virol. 2014 Feb;88(3):1492-501
  Gupta S et al
  2014/01/01
  
• 備考：
  Species: Mouse, Applications: Western Blot
• 参照：
  

• No.： 4
• 文献情報：
  Akiyama T et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 2008 Sep;29(3):423-37
  Akiyama T et al
  2008/01/01
  
• 備考：
  Species: Mouse, Applications: IHC-P
• 参照：
  

• No.： 5
• 文献情報：
  Koguchi Y et al. Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood 2007 Oct;110(7):2520-7
  Koguchi Y et al
  2007/01/01
  
• 備考：
  Species: Mouse, Applications: ICC
• 参照：
  

• No.： 6
• 文献情報：
  Russell MS et al. Identification and characterisation of the CD40-ligand of Sigmodon hispidus. PLoS ONE 2018;13(7):e0199067
  Russell MS et al
  2018/01/01
  
• 備考：
  Species: Mouse, Applications: ELISA Development
• 参照：
  

• No.： 7
• 文献情報：
  Field AE et al. Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand. Infect. Immun. 2007 Jun;75(6):3140-9
  Field AE et al
  2007/01/01
  
• 備考：
  Species: Human, Applications: ELISA Development
• 参照：